Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1996
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740700A1 Natural resistance associated macrophage protein and uses thereof
11/06/1996EP0740552A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
11/06/1996EP0740547A1 Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
11/06/1996EP0729361A4 Method of treating neurological disorders
11/06/1996EP0652901A4 Carboxy terminal il-6 muteins.
11/06/1996EP0580642B1 Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
11/06/1996EP0413763B1 Method for the production of monoclonal antibodies utilizing a germfree animal
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/06/1996CN1135212A Polar-substituted hydrocarbons
11/06/1996CN1135181A Alteration of immune response using pan Dr-binding peptides
11/06/1996CN1135178A Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or doner, or a nitric oxide inhibitor
11/06/1996CN1134941A New pseudopeptides having trifluoromethyl substtuted 2-azazbicyclooctane
11/06/1996CN1134940A New acylated pseudopeptides containing trifluoromethyl-substituted 2-azabicyclooctane
11/06/1996CN1134840A Biological products made up mainly of gamma-linolenic acid, prepn. and application thereof
11/06/1996CA2175786A1 Igf-1 superagonists
11/06/1996CA2175298A1 Recombinant obese (ob) proteins
11/05/1996US5571900 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof
11/05/1996US5571896 Production of recombinant human lactoferrin
11/05/1996US5571895 Modified GAF polypeptides
11/05/1996US5571894 Recombinant antibodies specific for a growth factor receptor
11/05/1996US5571893 Cardiac hypertrophy factor
11/05/1996US5571892 Polypeptide and anti-HIV drug prepared therefrom
11/05/1996US5571844 Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
11/05/1996US5571840 Method for treating central nervous system ischemia
11/05/1996US5571839 D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors
11/05/1996US5571835 Inhibitors of farnesyl-protein transferase
11/05/1996US5571834 Pharmaceutical composition useful for the treatment of cardiovascular diseases
11/05/1996US5571797 Method of inducing gene expression by ionizing radiation
11/05/1996US5571792 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
11/05/1996US5571791 Modified polypeptide fragments of the glucocorticoid receptor
11/05/1996US5571790 Having specified amino acid sequence and free of proteins of human origin; medical diagnosis; treatment of damaged blood vessels
11/05/1996US5571789 Use of urodilatin in pulmonary and bronchial diseases
11/05/1996US5571788 Stable calcitonin pharmaceutical compositions
11/05/1996US5571787 Prosaposin as a neurotrophic factor
11/05/1996US5571786 Analgesics and antiinflammatory agents
11/05/1996US5571784 Use of VWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
11/05/1996US5571783 Composition and method for treating patients with hepatic disease
11/05/1996US5571718 Cloning and expression of soluble truncated variants of Borrelia OspA, OspB and Vmp7
11/05/1996US5571714 Treatment of acute liver injury
11/05/1996US5571713 Therapeutic treatment for inhibiting vascular restenosis
11/05/1996US5571711 Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
11/05/1996US5571710 CDNA coding for carcinoembryonic antigen
11/05/1996US5571708 Thrombin-activatable plasminogen activator
11/05/1996US5571702 Amplification method for detection of human PF4A receptors
11/05/1996US5571701 Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
11/05/1996US5571698 Genetic package, chimeric
11/05/1996US5571697 Plasmid dna sequences from cultures of fungal cells with promoters
11/05/1996US5571695 Dna and sequences for genomes
11/05/1996US5571694 Expression of tetanus toxin fragment C in yeast
11/05/1996US5571691 Genetic engineering with dna
11/05/1996US5571686 Method of using megapoietin for prolonging the survival & viability of platlets
11/05/1996US5571675 Detection and amplification of candiotrophin-1(cardiac hypertrophy factor)
11/05/1996US5571523 Antioxidant-induced apoptosis in vascular smooth muscle cells
11/05/1996US5571515 Compositions and methods for use of IL-12 as an adjuvant
11/05/1996US5571513 Which specifically binds to extracellular domain of human cytokine receptor
11/05/1996US5571512 Pharmaceutical composition against AIDS
11/05/1996US5571511 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/05/1996US5571510 Method for selective methionine starvation of malignant cells in mammals
11/05/1996US5571509 Protein
11/05/1996US5571508 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
11/05/1996US5571507 Methods of treating diabetes
11/05/1996US5571500 Treatment of autoimmune diseases through administration by inhalation of autoantigens
11/05/1996US5571499 Treatment of diseases with autoimmune fragments and collagen
10/1996
10/31/1996WO1996034288A1 Human brain sodium-dependent inorganic phosphate cotransporter
10/31/1996WO1996034113A2 Methods for the identification of farnesyltransferase inhibitors
10/31/1996WO1996034111A1 Process for preparing anti-obesity protein
10/31/1996WO1996034109A1 Single-vial formulations of dna/lipid complexes
10/31/1996WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034103A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/31/1996WO1996034102A1 Purified mammalian t cell antigen crtam
10/31/1996WO1996034101A1 Utrophin gene promoter
10/31/1996WO1996034100A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996WO1996034096A1 Human antibodies derived from immunized xenomice
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996034093A1 Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
10/31/1996WO1996034016A1 Novel polypeptides
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996034014A1 Bacteriocins produced by ruminal bacteria
10/31/1996WO1996034013A1 Antigen peptide compound and immunoassay method
10/31/1996WO1996034012A1 Cyclic pentapeptide lh-rh receptor antagonists
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996034009A1 Chimeric nucleic acids and proteins for inhibiting hiv-1 expression
10/31/1996WO1996034008A1 Novel antisense nucleic acids directed against ras oncogenes, their preparation and use
10/31/1996WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
10/31/1996WO1996033993A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996WO1996033984A1 N-sulfoxy anhydrides, a process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
10/31/1996WO1996033746A1 Treatment of tumors with cells expressing interferons, tumor necrosis factors, or other cytokines
10/31/1996WO1996033740A1 Use of leukemia inhibitory factor and endothelin antagonists
10/31/1996WO1996033735A1 Human antibodies derived from immunized xenomice
10/31/1996WO1996033734A1 A pluripotent vaccine against enveloped viruses
10/31/1996WO1996033733A1 Novel remedy for skin deficiencies
10/31/1996WO1996033731A1 Methods of using neurotrophic factors to enhance neuronal grafts
10/31/1996WO1996033730A2 Chemokine binding protein and methods of use therefor
10/31/1996WO1996033729A1 Antagonists of lhrh
10/31/1996WO1996033719A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
1 ... 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 ... 3163